- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
March 26, 2024Ronald Schutz, Brendan Johnson Named to Forbes Top 200 Lawyers in the United States
-
March 21, 2024Robins Kaplan Firm Members Appointed to Law360 Editorial Boards
-
March 20, 2024Brandon Vaughn Inducted into The International Society of Barristers
-
April 5, 2024Mass Torts Made Perfect
-
April 17, 2024American Antitrust Institute Virtual CLE Lunch & Learn
-
May 2-3, 2024ACI Advanced Forum on Managed Care Disputes and Litigation
-
March 14, 2024How Many Cases Have You Tried to a Verdict?
-
March 2024Do We Have to Share That Information? Attorney-Client Privilege in the Multi-Entity Context
-
March 2024Sellers of a Business: Know Thyself.
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Generic Launches
Fall 2020
This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications.
Reference Listed Drug | NDA Holder | Generic Drug Name | ANDA Applicant(s) |
Indication | Launch Date |
---|---|---|---|---|---|
Prolixin | Bristol-Myers Squibb | fluphenazine | Amneal | Used to treat schizophrenia | 7/10/2020 |
Nicorette Lozenges | Glaxo | nicotine polacrilex | Dr. Reddy's | Used to aid in smoking cessation in adults | 7/14/2020 |
Cubicin | Merck | daptomycin | Sandoz | Used to treat adult patients with complicated skin and skin structure infections | 7/13/2020 |
Mexitil | Boehringer Ingelheim | mexiletine | Lannett | Used to treat documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening | 7/23/2020 |
Cyklokapron | ANI | tranexamic acid | Apotex | Used to treat cyclic heavy menstrual bleeding | 7/29/2020 |
Zyclara | Bausch & Lomb | imiquimod | Teva | Used topically to treat clinically typical visible or palpable, actinic keratoses (AK) of the full face or balding scalp in immunocompetent adults; the treatment of external genital and perianal warts (EGW)/condyloma acuminata in patients 12 years or older | 7/30/2020 |
Levo-T | Cediprof | levothyroxine sodium | Lannett | Used to treat an underactive thyroid gland (hypothyroidism) | 8/3/2020 |
Canasa | Allergan | mesalamine | Camber | Used to treat a certain bowel disease (ulcerative colitis) | 8/3/2020 |
Ciprodex | Novartis | ciprofloxacin / dexamethasone | Dr. Reddy's | Used to treat infections caused by susceptible isolates of the designated microorganisms in the specific conditions Acute Otitis Media in pediatric patients and Acute Otitis Externa |
8/11/2020 |
Yaz | Bayer | drospirenone / ethyl estradiol | Camber | Used as a contraception to prevent pregnancy | 8/11/2020 |
Zyflo CR | Chiesi | zileuton | Lupin | Used for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older | 8/11/2020 |
Effexor XR | Pfizer | venlafaxine | Hetero | Used to treat major depressive disorder, anxiety and panic disorder | 8/13/2020 |
Tecfidera | Biogen | dimethyl fumarate | Mylan | Used to treat relapsing forms of multiple sclerosis (MS) | 8/19/2020 |
Revatio | Pfizer | sildenafil | Teva | Used to treat erectile dysfunction (impotence) in men | 8/19/2020 |
Rapaflo | Allergan | silodosin | Hetero | Used to treat the signs and symptoms of Benign Prostatic Hyperplasia (BPH) | 8/21/2020 |
Cuprimine | Bausch & Lomb | penicillamine 250mg capsules | Dr. Reddy's | Used to treat Wilson’s disease, cystinuria, and in patients with severe, active rheumatoid arthritis who have failed to respond to an adequate trial of conventional therapy | 8/27/2020 |
Cleocin T gel | Pfizer | clindamycin | Solaris | Used topically to treat acne vulgaris in patients 12 years or older | 8/31/2020 |
MoviPrep | Bausch & Lomb | PEG-3350 / sodium sulfate / sodium chloride / potassium / sodium ascorbate | Teva | Used to cleanse the colon as a preparation for colonoscopy in adults | 8/31/2020 |
Concerta | Johnson & Johnson | methylphenidate | Dr. Reddy's | Used to treat Attention Deficit Hyperactivity Disorder (ADHD) | 9/3/2020 |
Arava | Sanofi | leflunomide | Lupin | Used to treat adults with active rheumatoid arthritis (RA) | 9/2/2020 |
Bafiertam | Banner | monomethyl fumarate | Banner | Used to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease | 9/3/2020 |
Voltaren gel | Glaxo | diclofenac | Perrigo | Used to relieve pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands | 9/8/2020 |
Voltaren gel | Glaxo | diclofenac | Dr. Reddy's | Used to relieve pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands | 9/9/2020 |
Bethkis | Chiesi | tobramycin | Teva | Used to manage cystic fibrosis patients with P. aeruginosa | 9/15/2020 |
Pataday | Novartis | olopatadine | Dr. Reddy's | Used to temporary relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander | 9/17/2020 |
Depakote ER | AbbVie | divalproex | Lupin | Used to treat manic or mixed episodes associated with bipolar disorder, with or without psychotic features; monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures; Prophylaxis of migraine headaches | 9/22/2020 |
Tecfidera | Biogen | dimethyl fumarate | Camber | Used to treat relapsing forms of multiple sclerosis | 9/24/2020 |
Tecfidera | Biogen | dimethyl fumarate | Cipla | Used to treat relapsing forms of multiple sclerosis | 9/25/2020 |
Precedex | Hospira | dexmedetomidine | Dr. Reddy's | Used for sedation of non-intubated patients prior to and/or during surgical and other procedures | 9/25/2020 |
Tecfidera | Biogen | dimethyl fumarate | Dr. Reddy's | Used to treat relapsing forms of multiple sclerosis | 9/26/2020 |
Ferriprox | Chiesi | deferiprone | Taro | Used to treat patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate | 9/28/2020 |
Tecfidera | Biogen | dimethyl fumarate | Teva | Used to treat relapsing forms of multiple sclerosis | 9/28/2020 |
Tykerb | Glaxo | lapatinib | Lupin | Used to treat advanced hormone-related breast cancer that has progressed or spread after treatment with other cancer medicines | 9/30/2020 |
GENERICally Speaking Fall 2020
Related Professionals
Christopher A. Pinahs
Partner
GENERICally Speaking Fall 2020
VOL. 10, NO. 3 Related Publications
Fourth Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
December 29, 2023
Corcept Therapeutics, Inc. v. Teva Pharms. USA, Inc.
GENERICally Speaking Hatch Waxman Bulletin
December 13, 2023
Acadia Pharms. Inc. v. Aurobindo Pharma Ltd.
GENERICally Speaking Hatch Waxman Bulletin
December 7, 2023
H. Lundbeck A/S v. Lupin Ltd.
GENERICally Speaking Hatch Waxman Bulletin
November 7, 2023
Eisai R&D Mgmt. Co., Ltd. v. Dr Reddy’s Labs., Inc.
GENERICally Speaking Hatch Waxman Bulletin
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.